Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Community-acquired pneumonia in influenza season: There's a bad strain on the rise

09.11.2009
ROME - Infections due to methicillin-resistant Staphylococcus aureus (MRSA) strains are no longer confined to hospitals but occur more and more in communities.

Two articles in the European Respiratory Journal's November issue are dedicated to this dangerous and versatile microorganism.

For many years, MRSA infections were associated with hospitalised, high-risk patients.

Not only has the infection pattern recently shifted from hospital-acquired (nosocomial) to community-onset infections, but new strains have emerged, affecting young individuals, who don't have any risk factors. It seems that everything we know about these bacteria is becoming obsolete, to such an extent that a group of Italian researchers are now asking: "What is MRSA?"

This question (and the answer) is dealt with by Dr. Annalisa Pantosi from the Istituto Superiore di Sanita in Rome, Italy, and her colleagues in a current ERJ article.

Besides the hospital setting, every doctor associates MRSA with being a multiresistant bacterial pathogen - after all, even its name is based on its antibiotic sensitivity (or lack thereof). Able to destroy penicillin by producing an enzyme called penicillinase, MRSA earned its name because of a sophisticated genetic adaptation that enables it to bypass the effects of Methicillin, which blocks construction and maintenance of the bacterial cell wall. As a consequence, MRSA is resistant not only to methicillin but also to all beta-lactam antibiotics, including cephalosporins and carbapanems.

Staphylococcal infections are a concern not only from the respiratory point of view - the organ system commonly involved is the skin, with furunculosis and impetigo being frequent manifestations. In addition, they can result in serious bloodstream infections (sepsis) and can infect prosthetic implants.

The "new generation" of MRSA strains commonly causes skin and soft- tissue infections. However, even if cases of community-acquired pneumonia due to MRSA are still rare, when respiratory infections occur, they are severe and carry a high mortality.

"The estimated incidence is 0.51-0.64 cases per 100.000 people" report Dr. Konstantinos Vardakas and his colleagues from the Alfa Institute of Biomedical Sciences in Athens, Greece.

In Europe, the prevalence of infections due to this community-acquired MRSA (CA-MRSA) strain is lower than in the US. Nevertheless, physicians need to be aware of any infection that might be caused by a potentially multiple-drug resistant strain.

Moreover, MRSA-pneumonia in the community setting is often preceded by influenza or an influenza-like illness, a phenomenon that may well become relevant in the upcoming influenza season and amid the ongoing pandemic of H1N1 influenza, writes Dr. Alexandra Nakou in an accompanying editorial.

Dr. Nakou adds: "Although community-acquired MRSA is sensitive to several antibiotics such as clindamycin, trimethoprim-sulphamethoxazole and tetracyclines, the optimal treatment is not yet established. The current guidelines recommend the use of vancomycin or linezolid."

"MRSA should be part of the differential diagnosis of severe pneumonia during the influenza season, especially in patients with evidence of necrosis and in those with a history of MRSA infection".

Dr. Anka Stegmeier-Petroianu | idw
Further information:
http://www.ersnet.org

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>